Composite urinary and sexual outcomes after Rezum: an analysis of predictive factors from an Italian multi-centric study
Background The Rezum system is one of the latest minimally invasive surgical treatments for benign prostatic hyperplasia. Methods We retrospectively reviewed all patients who underwent the Rezum treatment in seven different Italian institutions. A successful urinary outcome was defined as: ≥50% impr...
Gespeichert in:
| Veröffentlicht in: | Prostate cancer and prostatic diseases 2023-06, Vol.26 (2), p.410-414 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 414 |
|---|---|
| container_issue | 2 |
| container_start_page | 410 |
| container_title | Prostate cancer and prostatic diseases |
| container_volume | 26 |
| creator | Campobasso, Davide Siena, Giampaolo Chiodini, Paolo Conti, Enrico Franzoso, Francesco Maruzzi, Daniele Martinelli, Evangelista Varvello, Francesco De Nunzio, Cosimo Autorino, Riccardo Somani, Bhaskar Kumar Ferrari, Giovanni Cindolo, Luca |
| description | Background
The Rezum system is one of the latest minimally invasive surgical treatments for benign prostatic hyperplasia.
Methods
We retrospectively reviewed all patients who underwent the Rezum treatment in seven different Italian institutions. A successful urinary outcome was defined as: ≥50% improvement in the IPSS |
| doi_str_mv | 10.1038/s41391-022-00587-6 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2708734446</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2826827999</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-3ae5209ba6126ba5c78f05c55aed06d50b580c1a6b93359ff9bba2eb9309cc6c3</originalsourceid><addsrcrecordid>eNp9kV2LVSEUhiWK5qP-QBchdNONtdStW7uLQ00DA0HUtbjdGg57b09-xJx-fZ7OVNBFICzFx1fWehB6RuEVBa5el4FyTQkwRgCEGol8gM7pMEoiJKiHfc-lIKMS7AxdlHILAJpqeIzOuISBMS3O0d0urftUYvW45bjZfMB2m3Hxd80uOLXq0uoLtqH6jD_5H21904G-7HIoseAU8D77Oboav3scrKspFxxyWo_YdbVL7HVtS43E-a3m6HCpbT48QY-CXYp_el8v0Zf37z7vPpCbj1fXu7c3xPFRVMKtFwz0ZCVlcrLCjSqAcEJYP4OcBUxCgaNWTppzoUPQ02SZ7yfQzknHL9HLU-4-p2_Nl2rWWJxfFrv51IphI6iRD8MgO_riH_Q2tdw77ZRiUrFRa90pdqJcTqVkH8w-x7UPzlAwRy_m5MV0L-aXF3OMfn4f3abVz3-e_BbRAX4CSr_avvr89-__xP4EZ4CaQw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2826827999</pqid></control><display><type>article</type><title>Composite urinary and sexual outcomes after Rezum: an analysis of predictive factors from an Italian multi-centric study</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Campobasso, Davide ; Siena, Giampaolo ; Chiodini, Paolo ; Conti, Enrico ; Franzoso, Francesco ; Maruzzi, Daniele ; Martinelli, Evangelista ; Varvello, Francesco ; De Nunzio, Cosimo ; Autorino, Riccardo ; Somani, Bhaskar Kumar ; Ferrari, Giovanni ; Cindolo, Luca</creator><creatorcontrib>Campobasso, Davide ; Siena, Giampaolo ; Chiodini, Paolo ; Conti, Enrico ; Franzoso, Francesco ; Maruzzi, Daniele ; Martinelli, Evangelista ; Varvello, Francesco ; De Nunzio, Cosimo ; Autorino, Riccardo ; Somani, Bhaskar Kumar ; Ferrari, Giovanni ; Cindolo, Luca</creatorcontrib><description>Background
The Rezum system is one of the latest minimally invasive surgical treatments for benign prostatic hyperplasia.
Methods
We retrospectively reviewed all patients who underwent the Rezum treatment in seven different Italian institutions. A successful urinary outcome was defined as: ≥50% improvement in the IPSS <7, improvement in peak flow ≥50% and/or more than 15 ml/s, ≥1-point improvement in the QoL questionnaire and in the absence of perioperative major complications (AUR, transfusion) or postoperative incontinence. A successful sexual outcome was defined as postoperative (latest follow up consultation) antegrade ejaculation or no variation in ejaculatory function and an increase, or stability or max 1 class reduction, in IIEF-5.
Results
262 patients were enrolled with a follow-up period of 11 months (IQR 5–15). No early or late serious adverse events (Clavien III–IV) occurred. Early complications occurred in 39.3% of cases, with 4 cases of clot retention and one case of blood transfusion. Urge incontinence was reported by 6 patients (2.2%). A treatment failure requiring re-intervention occurred in 4 cases (1.5%). The preoperative antegrade ejaculation rate was 56.5%, and after the procedure it increased to 78.2%. The increase of ≥1-point in the QoL was achieved in 92.7% of the cases. Optimal urinary and sexual outcomes were achieved in 52.9% and 87.8%, respectively.
Conclusions
In our series, water vapor intraprostatic injections seem to be an effective and safe procedure.</description><identifier>ISSN: 1365-7852</identifier><identifier>EISSN: 1476-5608</identifier><identifier>DOI: 10.1038/s41391-022-00587-6</identifier><identifier>PMID: 36042295</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/308/409 ; 692/699/2768/1753 ; Biomedical and Life Sciences ; Biomedicine ; Blood transfusion ; Cancer Research ; Complications ; Ejaculation ; Humans ; Hyperplasia ; Intervention ; Lower Urinary Tract Symptoms - etiology ; Male ; Medical treatment ; Prostate ; Prostatic Hyperplasia - complications ; Prostatic Neoplasms - complications ; Quality of Life ; Reproductive Medicine ; Retrospective Studies ; Sexual health ; Surgical outcomes ; Transfusion ; Treatment Outcome ; Urinary incontinence ; Urological surgery ; Water vapor</subject><ispartof>Prostate cancer and prostatic diseases, 2023-06, Vol.26 (2), p.410-414</ispartof><rights>The Author(s), under exclusive licence to Springer Nature Limited 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2022. The Author(s), under exclusive licence to Springer Nature Limited.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-3ae5209ba6126ba5c78f05c55aed06d50b580c1a6b93359ff9bba2eb9309cc6c3</citedby><cites>FETCH-LOGICAL-c375t-3ae5209ba6126ba5c78f05c55aed06d50b580c1a6b93359ff9bba2eb9309cc6c3</cites><orcidid>0000-0003-1436-9354 ; 0000-0002-0712-2719 ; 0000-0002-2190-512X ; 0000-0003-2072-114X ; 0000-0002-5481-9930 ; 0000-0001-7045-7725</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/s41391-022-00587-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/s41391-022-00587-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36042295$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Campobasso, Davide</creatorcontrib><creatorcontrib>Siena, Giampaolo</creatorcontrib><creatorcontrib>Chiodini, Paolo</creatorcontrib><creatorcontrib>Conti, Enrico</creatorcontrib><creatorcontrib>Franzoso, Francesco</creatorcontrib><creatorcontrib>Maruzzi, Daniele</creatorcontrib><creatorcontrib>Martinelli, Evangelista</creatorcontrib><creatorcontrib>Varvello, Francesco</creatorcontrib><creatorcontrib>De Nunzio, Cosimo</creatorcontrib><creatorcontrib>Autorino, Riccardo</creatorcontrib><creatorcontrib>Somani, Bhaskar Kumar</creatorcontrib><creatorcontrib>Ferrari, Giovanni</creatorcontrib><creatorcontrib>Cindolo, Luca</creatorcontrib><title>Composite urinary and sexual outcomes after Rezum: an analysis of predictive factors from an Italian multi-centric study</title><title>Prostate cancer and prostatic diseases</title><addtitle>Prostate Cancer Prostatic Dis</addtitle><addtitle>Prostate Cancer Prostatic Dis</addtitle><description>Background
The Rezum system is one of the latest minimally invasive surgical treatments for benign prostatic hyperplasia.
Methods
We retrospectively reviewed all patients who underwent the Rezum treatment in seven different Italian institutions. A successful urinary outcome was defined as: ≥50% improvement in the IPSS <7, improvement in peak flow ≥50% and/or more than 15 ml/s, ≥1-point improvement in the QoL questionnaire and in the absence of perioperative major complications (AUR, transfusion) or postoperative incontinence. A successful sexual outcome was defined as postoperative (latest follow up consultation) antegrade ejaculation or no variation in ejaculatory function and an increase, or stability or max 1 class reduction, in IIEF-5.
Results
262 patients were enrolled with a follow-up period of 11 months (IQR 5–15). No early or late serious adverse events (Clavien III–IV) occurred. Early complications occurred in 39.3% of cases, with 4 cases of clot retention and one case of blood transfusion. Urge incontinence was reported by 6 patients (2.2%). A treatment failure requiring re-intervention occurred in 4 cases (1.5%). The preoperative antegrade ejaculation rate was 56.5%, and after the procedure it increased to 78.2%. The increase of ≥1-point in the QoL was achieved in 92.7% of the cases. Optimal urinary and sexual outcomes were achieved in 52.9% and 87.8%, respectively.
Conclusions
In our series, water vapor intraprostatic injections seem to be an effective and safe procedure.</description><subject>692/308/409</subject><subject>692/699/2768/1753</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Blood transfusion</subject><subject>Cancer Research</subject><subject>Complications</subject><subject>Ejaculation</subject><subject>Humans</subject><subject>Hyperplasia</subject><subject>Intervention</subject><subject>Lower Urinary Tract Symptoms - etiology</subject><subject>Male</subject><subject>Medical treatment</subject><subject>Prostate</subject><subject>Prostatic Hyperplasia - complications</subject><subject>Prostatic Neoplasms - complications</subject><subject>Quality of Life</subject><subject>Reproductive Medicine</subject><subject>Retrospective Studies</subject><subject>Sexual health</subject><subject>Surgical outcomes</subject><subject>Transfusion</subject><subject>Treatment Outcome</subject><subject>Urinary incontinence</subject><subject>Urological surgery</subject><subject>Water vapor</subject><issn>1365-7852</issn><issn>1476-5608</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kV2LVSEUhiWK5qP-QBchdNONtdStW7uLQ00DA0HUtbjdGg57b09-xJx-fZ7OVNBFICzFx1fWehB6RuEVBa5el4FyTQkwRgCEGol8gM7pMEoiJKiHfc-lIKMS7AxdlHILAJpqeIzOuISBMS3O0d0urftUYvW45bjZfMB2m3Hxd80uOLXq0uoLtqH6jD_5H21904G-7HIoseAU8D77Oboav3scrKspFxxyWo_YdbVL7HVtS43E-a3m6HCpbT48QY-CXYp_el8v0Zf37z7vPpCbj1fXu7c3xPFRVMKtFwz0ZCVlcrLCjSqAcEJYP4OcBUxCgaNWTppzoUPQ02SZ7yfQzknHL9HLU-4-p2_Nl2rWWJxfFrv51IphI6iRD8MgO_riH_Q2tdw77ZRiUrFRa90pdqJcTqVkH8w-x7UPzlAwRy_m5MV0L-aXF3OMfn4f3abVz3-e_BbRAX4CSr_avvr89-__xP4EZ4CaQw</recordid><startdate>20230601</startdate><enddate>20230601</enddate><creator>Campobasso, Davide</creator><creator>Siena, Giampaolo</creator><creator>Chiodini, Paolo</creator><creator>Conti, Enrico</creator><creator>Franzoso, Francesco</creator><creator>Maruzzi, Daniele</creator><creator>Martinelli, Evangelista</creator><creator>Varvello, Francesco</creator><creator>De Nunzio, Cosimo</creator><creator>Autorino, Riccardo</creator><creator>Somani, Bhaskar Kumar</creator><creator>Ferrari, Giovanni</creator><creator>Cindolo, Luca</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>M7Z</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1436-9354</orcidid><orcidid>https://orcid.org/0000-0002-0712-2719</orcidid><orcidid>https://orcid.org/0000-0002-2190-512X</orcidid><orcidid>https://orcid.org/0000-0003-2072-114X</orcidid><orcidid>https://orcid.org/0000-0002-5481-9930</orcidid><orcidid>https://orcid.org/0000-0001-7045-7725</orcidid></search><sort><creationdate>20230601</creationdate><title>Composite urinary and sexual outcomes after Rezum: an analysis of predictive factors from an Italian multi-centric study</title><author>Campobasso, Davide ; Siena, Giampaolo ; Chiodini, Paolo ; Conti, Enrico ; Franzoso, Francesco ; Maruzzi, Daniele ; Martinelli, Evangelista ; Varvello, Francesco ; De Nunzio, Cosimo ; Autorino, Riccardo ; Somani, Bhaskar Kumar ; Ferrari, Giovanni ; Cindolo, Luca</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-3ae5209ba6126ba5c78f05c55aed06d50b580c1a6b93359ff9bba2eb9309cc6c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>692/308/409</topic><topic>692/699/2768/1753</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Blood transfusion</topic><topic>Cancer Research</topic><topic>Complications</topic><topic>Ejaculation</topic><topic>Humans</topic><topic>Hyperplasia</topic><topic>Intervention</topic><topic>Lower Urinary Tract Symptoms - etiology</topic><topic>Male</topic><topic>Medical treatment</topic><topic>Prostate</topic><topic>Prostatic Hyperplasia - complications</topic><topic>Prostatic Neoplasms - complications</topic><topic>Quality of Life</topic><topic>Reproductive Medicine</topic><topic>Retrospective Studies</topic><topic>Sexual health</topic><topic>Surgical outcomes</topic><topic>Transfusion</topic><topic>Treatment Outcome</topic><topic>Urinary incontinence</topic><topic>Urological surgery</topic><topic>Water vapor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Campobasso, Davide</creatorcontrib><creatorcontrib>Siena, Giampaolo</creatorcontrib><creatorcontrib>Chiodini, Paolo</creatorcontrib><creatorcontrib>Conti, Enrico</creatorcontrib><creatorcontrib>Franzoso, Francesco</creatorcontrib><creatorcontrib>Maruzzi, Daniele</creatorcontrib><creatorcontrib>Martinelli, Evangelista</creatorcontrib><creatorcontrib>Varvello, Francesco</creatorcontrib><creatorcontrib>De Nunzio, Cosimo</creatorcontrib><creatorcontrib>Autorino, Riccardo</creatorcontrib><creatorcontrib>Somani, Bhaskar Kumar</creatorcontrib><creatorcontrib>Ferrari, Giovanni</creatorcontrib><creatorcontrib>Cindolo, Luca</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Prostate cancer and prostatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Campobasso, Davide</au><au>Siena, Giampaolo</au><au>Chiodini, Paolo</au><au>Conti, Enrico</au><au>Franzoso, Francesco</au><au>Maruzzi, Daniele</au><au>Martinelli, Evangelista</au><au>Varvello, Francesco</au><au>De Nunzio, Cosimo</au><au>Autorino, Riccardo</au><au>Somani, Bhaskar Kumar</au><au>Ferrari, Giovanni</au><au>Cindolo, Luca</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Composite urinary and sexual outcomes after Rezum: an analysis of predictive factors from an Italian multi-centric study</atitle><jtitle>Prostate cancer and prostatic diseases</jtitle><stitle>Prostate Cancer Prostatic Dis</stitle><addtitle>Prostate Cancer Prostatic Dis</addtitle><date>2023-06-01</date><risdate>2023</risdate><volume>26</volume><issue>2</issue><spage>410</spage><epage>414</epage><pages>410-414</pages><issn>1365-7852</issn><eissn>1476-5608</eissn><abstract>Background
The Rezum system is one of the latest minimally invasive surgical treatments for benign prostatic hyperplasia.
Methods
We retrospectively reviewed all patients who underwent the Rezum treatment in seven different Italian institutions. A successful urinary outcome was defined as: ≥50% improvement in the IPSS <7, improvement in peak flow ≥50% and/or more than 15 ml/s, ≥1-point improvement in the QoL questionnaire and in the absence of perioperative major complications (AUR, transfusion) or postoperative incontinence. A successful sexual outcome was defined as postoperative (latest follow up consultation) antegrade ejaculation or no variation in ejaculatory function and an increase, or stability or max 1 class reduction, in IIEF-5.
Results
262 patients were enrolled with a follow-up period of 11 months (IQR 5–15). No early or late serious adverse events (Clavien III–IV) occurred. Early complications occurred in 39.3% of cases, with 4 cases of clot retention and one case of blood transfusion. Urge incontinence was reported by 6 patients (2.2%). A treatment failure requiring re-intervention occurred in 4 cases (1.5%). The preoperative antegrade ejaculation rate was 56.5%, and after the procedure it increased to 78.2%. The increase of ≥1-point in the QoL was achieved in 92.7% of the cases. Optimal urinary and sexual outcomes were achieved in 52.9% and 87.8%, respectively.
Conclusions
In our series, water vapor intraprostatic injections seem to be an effective and safe procedure.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>36042295</pmid><doi>10.1038/s41391-022-00587-6</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0003-1436-9354</orcidid><orcidid>https://orcid.org/0000-0002-0712-2719</orcidid><orcidid>https://orcid.org/0000-0002-2190-512X</orcidid><orcidid>https://orcid.org/0000-0003-2072-114X</orcidid><orcidid>https://orcid.org/0000-0002-5481-9930</orcidid><orcidid>https://orcid.org/0000-0001-7045-7725</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1365-7852 |
| ispartof | Prostate cancer and prostatic diseases, 2023-06, Vol.26 (2), p.410-414 |
| issn | 1365-7852 1476-5608 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2708734446 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | 692/308/409 692/699/2768/1753 Biomedical and Life Sciences Biomedicine Blood transfusion Cancer Research Complications Ejaculation Humans Hyperplasia Intervention Lower Urinary Tract Symptoms - etiology Male Medical treatment Prostate Prostatic Hyperplasia - complications Prostatic Neoplasms - complications Quality of Life Reproductive Medicine Retrospective Studies Sexual health Surgical outcomes Transfusion Treatment Outcome Urinary incontinence Urological surgery Water vapor |
| title | Composite urinary and sexual outcomes after Rezum: an analysis of predictive factors from an Italian multi-centric study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T16%3A17%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Composite%20urinary%20and%20sexual%20outcomes%20after%20Rezum:%20an%20analysis%20of%20predictive%20factors%20from%20an%20Italian%20multi-centric%20study&rft.jtitle=Prostate%20cancer%20and%20prostatic%20diseases&rft.au=Campobasso,%20Davide&rft.date=2023-06-01&rft.volume=26&rft.issue=2&rft.spage=410&rft.epage=414&rft.pages=410-414&rft.issn=1365-7852&rft.eissn=1476-5608&rft_id=info:doi/10.1038/s41391-022-00587-6&rft_dat=%3Cproquest_cross%3E2826827999%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2826827999&rft_id=info:pmid/36042295&rfr_iscdi=true |